Home / Knowledge Centre /
Case study

Ultra Low Temperature Packaging solutions

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable or chronic conditions that do not respond adequately to more conventional treatments. In many cases, these treatments are curative, making them life altering and even lifesaving. These products, which include cell and gene therapies (CGT) typically have very rigid temperature requirements that pose unique challenges throughout the supply chain. Often, they must be held at ultra-low temperatures (ULT) between -20 and -80⁰C, with very little scope or time for deviation away from these target temperatures.

This case study explains the business challenge Almac faced from a CDMO perspective, and the resolution to this challenge.

Download the case study to learn more.

View Resource
Almac Logo

Commercial Services

Almac Pharma Services provide a wide range of customised commercial services from supporting product launch, manufacturing and / or packaging drug product, to securing supply chain with global serialisation solutions.

Our flexible, quality-led commercial solutions range from orphan drug launches to ongoing high-volume commercial product manufacture, packaging and supply.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies